What Is TB-500? Thymosin Beta-4 Research Overview

Introduction to TB-500

TB-500 is the research designation for a synthetic peptide corresponding to a biologically active region of the naturally occurring protein thymosin beta-4 (Tβ4). The compound has generated significant interest in the research community due to its documented interactions with actin in published in-vitro studies. As an increasingly studied peptide in laboratory settings, TB-500 represents a valuable research tool for investigators examining cytoskeletal dynamics and related cellular processes.

The compound is identified under CAS number 77591-33-4 and consists of a 43 amino acid sequence. Its primary relevance to researchers lies in the extensive published literature documenting its molecular interactions in controlled laboratory environments. Origin Research Labs provides TB-500 at >99.715% purity, verified by independent third-party analysis from Janoshik Analytical.

Thymosin Beta-4: The Parent Protein

Thymosin beta-4 is a 43 amino acid polypeptide first isolated from thymic tissue. In published literature, it has been identified as one of the most abundant intracellular peptides across a wide range of cell types studied in vitro. The protein belongs to the beta-thymosin family, a group of highly conserved small acidic proteins characterized by their interaction with monomeric actin (G-actin).

Research published in peer-reviewed journals has characterized Tβ4 as the principal G-actin-sequestering peptide within cells examined under laboratory conditions. Its sequence is highly conserved across mammalian species, which has made it a subject of comparative molecular biology studies. The synthetic form, designated TB-500, reproduces the complete amino acid sequence to enable consistent and reproducible laboratory research.

The initial isolation and characterization of thymosin beta-4 dates to the 1960s and 1970s, when researchers identified a family of small peptides in thymic extracts. Since that time, hundreds of peer-reviewed publications have documented its molecular properties, binding interactions, and behavior in various in-vitro experimental systems.

Actin Regulation Research In Vitro

The most extensively documented function of TB-500 in published research relates to actin dynamics. Actin is a fundamental structural protein in cells, existing in two forms: monomeric globular actin (G-actin) and polymerized filamentous actin (F-actin). The balance between these two states is critical to cytoskeletal architecture, and researchers have studied TB-500's interaction with this system extensively in controlled laboratory environments.

In-vitro binding assays have demonstrated that TB-500 forms a 1:1 complex with G-actin. This interaction has been mapped to a specific region of the peptide sequence, and crystallographic studies have provided detailed structural data on the binding interface. The central actin-binding motif, identified as the sequence LKKTET (amino acids 17-22), has been shown through mutagenesis studies to be essential for actin interaction in reconstituted systems.

Published research in journals such as the Journal of Biological Chemistry and Cell Motility and the Cytoskeleton has demonstrated that the presence of TB-500 in cell-free actin polymerization assays modulates the rate and extent of filament assembly. These observations have made the peptide a standard research tool in studies investigating the regulation of actin polymerization dynamics.

Key Published Findings on Actin Interaction

• TB-500 binds G-actin with a reported dissociation constant (K_d) in the low micromolar range as measured by fluorescence-based in-vitro assays
• The binding interaction involves the WH2 (WASP homology 2) domain, a conserved actin-binding motif found across multiple protein families
• In reconstituted actin systems, TB-500 has been observed to influence the critical concentration required for filament nucleation
• Cross-linking studies have mapped specific contact residues between the peptide and the actin monomer surface

Cellular Migration Studies

A significant body of in-vitro research has examined the effects of TB-500 on cellular migration using standard laboratory assays. Scratch wound assays (also known as wound-healing assays), Boyden chamber experiments, and transwell migration assays have all been employed by research groups to characterize this aspect of TB-500 activity in cultured cell populations.

Published studies in peer-reviewed literature have reported that the addition of TB-500 to culture media can influence migration patterns of various cell lines in these controlled assay systems. These observations have been documented across multiple independent research groups and institutions, lending reproducibility to the findings.

It is important to note that all such migration studies were conducted in vitro using standardized cell culture protocols. The results reflect the behavior of isolated cells in artificial culture conditions and are not indicative of effects in intact biological systems. Researchers use these assay platforms as tools to investigate molecular mechanisms and signaling pathways under controlled and reproducible conditions.

Molecular Signaling Research

Beyond direct actin interaction, published in-vitro research has explored TB-500 in the context of various intracellular signaling cascades. Studies using reporter gene assays, Western blot analysis, and phosphoproteomic approaches in cultured cell lines have investigated the peptide's relationship to several well-characterized signaling pathways.

Researchers have published data examining the relationship between TB-500 exposure and the activity of kinases, transcription factors, and other signaling intermediaries in cell-based assay systems. These studies contribute to the broader understanding of how actin-regulatory peptides intersect with intracellular signal transduction networks in laboratory models.

Published proteomic studies have also identified a range of intracellular binding partners for TB-500 beyond actin itself. Techniques including co-immunoprecipitation and yeast two-hybrid screening have expanded the known interactome of the peptide in experimental systems, suggesting it participates in multiple protein-protein interaction networks within the cellular context studied in vitro.

Structural Characterization

The three-dimensional structure of TB-500 has been characterized using nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, both independently and in complex with actin. In solution, the free peptide adopts a largely disordered conformation, consistent with the behavior of many intrinsically disordered proteins and peptides studied in structural biology.

When complexed with actin, however, structural studies reveal that TB-500 adopts a more ordered conformation. The N-terminal region forms an extended structure that contacts the actin surface, while the central LKKTET motif adopts a helical conformation upon binding. These structural data, published in journals including Structure and PNAS, provide atomic-level detail of the peptide-protein interaction interface.

The structural flexibility of free TB-500 is itself a subject of research interest. Intrinsically disordered peptides and proteins represent a growing area of molecular biology, and TB-500 serves as a model system for studying how disordered sequences adopt functional conformations upon interacting with structured binding partners.

Published Literature and Research History

TB-500 and its parent protein thymosin beta-4 have been the subject of hundreds of publications in the peer-reviewed scientific literature. The earliest characterization studies appeared in the 1970s, with research activity expanding significantly in subsequent decades as new molecular biology tools became available.

Key areas covered in the published literature include:

• Biochemical characterization of the actin-TB-500 interaction using purified protein systems
• Structural biology studies employing NMR and crystallography
• Gene expression profiling studies in cultured cell lines exposed to the peptide
• Comparative sequence analysis across species to examine evolutionary conservation
• Development of detection and quantification methods for the peptide in biological samples

Researchers interested in the published literature on TB-500 can access citations through databases including PubMed (NCBI), Google Scholar, and institutional library systems. The volume of available published data makes TB-500 one of the more thoroughly documented research peptides available to the scientific community.

Purity and Quality Considerations for Research

The quality of synthetic peptides is a critical factor in obtaining reliable and reproducible research data. Impurities, degradation products, and incorrect sequence synthesis can all introduce confounding variables into experimental systems. For this reason, researchers require peptide suppliers that provide rigorous quality documentation.

Origin Research Labs supplies TB-500 at >99.715% purity as verified by independent third-party testing conducted by Janoshik Analytical. Each batch is accompanied by a Certificate of Analysis (COA) documenting purity by HPLC, mass spectrometric confirmation of molecular identity, and assessment of residual solvent and peptide content. This level of analytical verification supports the integrity of downstream research applications.

Summary

TB-500 is a well-characterized 43 amino acid synthetic peptide (CAS 77591-33-4) corresponding to the naturally occurring protein thymosin beta-4. Its documented interactions with actin, its role in published cellular migration studies conducted in vitro, and its extensively characterized structure make it a valuable tool for laboratory research across multiple disciplines. The peptide's long history in the published scientific literature provides researchers with a robust foundation of prior data to inform experimental design and interpretation.